(Total Views: 694)
Posted On: 07/27/2023 4:48:16 PM
Post# of 148878
Agree the share price is cheap but there is more than one way to stop the bleeding. It can be a call to arms: “to the barricade!” with purchase orders but I’ll mention in passing over 4 million shares were borrowed short an hour before close, returned around the close. You can do a lot of damage with that volume of shares. Without news that turns the tide it’s easy to push the price down. Dedicated longs have tried to absorb the onslaught for a long time. I’ve lowered my average significantly but under strict orders from the better half to cease and desist. On the bright side there is a flip side we should remind ourselves of…I have mentioned before my sense is that extant shares are moving inexorably to people with faith and commitment….Walsh knows something about that. I’m sure the flippers are out there but many are holding on to their poker chips. When they light up the Saturn rocket I suspect they are not going to let go of those shares for cheap. Sold too soon is a lesson few learn, right up there with lacking the patience for a situation to develop. Borrowed shares must be bought back and when people see a rocket going to Tomorrowland they will want a seat and will have to pay for the privilege…tides move in two directions.
The OTHER way to help reverse the tide is for the Company to show up with something palpable. I think it will come in due course so I will wait for the game changing event, but NOW would be a good time to deliver on the change in communication strategy they talked about. Put some color on things; as mightycydy pointed out…why are we needing to do a preclinical study for NASH? Explain it…there must be a reason…one was already done and the mice liked how they felt in the treatment group…and we have something more valuable in a human study. Those mice sipping high fructose, high fat cocktails are not the same as positive data from a human trial. If we are going back to the mice for comment, explain it.
Right up there with truly market moving news quality communications would help…I hate being reduced to guessing, conjecture and reading entrails to divine what is going on.
The OTHER way to help reverse the tide is for the Company to show up with something palpable. I think it will come in due course so I will wait for the game changing event, but NOW would be a good time to deliver on the change in communication strategy they talked about. Put some color on things; as mightycydy pointed out…why are we needing to do a preclinical study for NASH? Explain it…there must be a reason…one was already done and the mice liked how they felt in the treatment group…and we have something more valuable in a human study. Those mice sipping high fructose, high fat cocktails are not the same as positive data from a human trial. If we are going back to the mice for comment, explain it.
Right up there with truly market moving news quality communications would help…I hate being reduced to guessing, conjecture and reading entrails to divine what is going on.
(9)
(0)
Scroll down for more posts ▼